Cycloalkl, aryl and heteroaryl amino isothiazoles for the treatment of Hepatitis C virus
    32.
    发明申请
    Cycloalkl, aryl and heteroaryl amino isothiazoles for the treatment of Hepatitis C virus 审中-公开
    环烷基,芳基和杂芳基氨基异噻唑,用于治疗丙型肝炎病毒

    公开(公告)号:US20060217390A1

    公开(公告)日:2006-09-28

    申请号:US11361581

    申请日:2006-02-24

    摘要: This invention concerns certain 5-(substituted amino) isothiazoles, compounds of Formula I, and salts thereof, where Q is CN, NHCONRaRb, or CONRaRb, where Ra and Rb are defined herein; and R1 is cyclohexyl, adamantan-1-yl, indan-1-yl, phenyl, benzyl, pyridyl, pyridylmethyl, or pyrimidyl, where all aromatic R1 groups are optionally substituted, provided that when R1 is phenyl, then R1 bears at least one non-alkyl substituent, and further provided that R1 is not 4-chloro-3-trichloromethyl-phenyl; The invention also concerns the tautomeric 5-(substituted amino)-isothiazol-3(2H)-ones, and the use of such compounds to treat Hepatitis C infection. It also concerns thiocarbamoyl acetamides, which are synthetic precursors to the isothiazoles.

    摘要翻译: 本发明涉及某些5-(取代氨基)异噻唑,式I化合物及其盐,其中Q为CN,NHCONR a R b B或CONR 其中R a a和R bb在本文中定义;其中R a,R b和R b都定义如上。 和R 1是环己基,金刚烷-1-基,茚满-1-基,苯基,苄基,吡啶基,吡啶基甲基或嘧啶基,其中所有芳族R 1〜 任选地被取代,条件是当R 1为苯基时,R 1至少具有一个非烷基取代基,并且进一步地,R 1' 不是4-氯-3-三氯甲基 - 苯基; 本发明还涉及互变异构5-(取代氨基) - 异噻唑-3(2H) - 酮,以及这些化合物用于治疗丙型肝炎感染的用途。 它还涉及硫代氨基甲酰基乙酰胺,它们是异噻唑的合成前体。